1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Dara Ganoczy, MPH, is affiliated with the VA Center for Clinical Management Research at the VA Ann Arbor Healthcare System in Michigan. The author has published extensively on topics including suicide risk, major depressive disorder, posttraumatic stress disorder, and schizophrenia/schizoaffective disorders. Their work focuses on clinical outcomes of treatments such as intravenous ketamine, factors influencing guideline-concordant medication dosing, suicide risk assessment and prediction among veterans, and medication adherence in schizophrenia. Ganoczy’s research spans from 2006 to 2024 and frequently involves collaboration with colleagues such as Marcia Valenstein and Eric G. Smith.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
